Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction
2000
Transgenic expression of proximal tubule peroxisome proliferator–activated receptor-α in mice confers protection during acute kidney injury
2009
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
New Developments in Anthracycline-Induced Cardiotoxicity
2009
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity
2007
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy
2002
DNA-Methylation Patterns in Trisomy 21 Using Cells from Monozygotic Twins
2015
Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria
2014
Doxorubicin pathways
2010 Standout
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
2010 Standout
Effects of adriamycin on heart mitochondrial function in rested and exercised rats
1994
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
1994
Effect of Aging on Cardiac Contractility in a Rat Model of Chronic Daunorubicin Cardiotoxicity
2002
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Autophagy and the Integrated Stress Response
2010 Standout
Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells
2007
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit
1993
Advances in metal-induced oxidative stress and human disease
2011 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of rats
2007
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Interference with Calcium-Dependent Mitochondrial Bioenergetics in Cardiac Myocytes Isolated from Doxorubicin-Treated Rats
2001
Molecular basis of physiological heart growth: fundamental concepts and new players
2012
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Effect of cationic side-chains on intracellular delivery and cytotoxicity of pH sensitive polymer–doxorubicin nanocarriers
2012
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
2006
Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
1995
Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity
2008
Sarcoplasmic Reticulum Calcium Release Is Stimulated and Inhibited by Daunorubicin and Daunorubicinol
2000
NOX5: from basic biology to signaling and disease
2011
Propionyl-l-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model
2006
Molecular mechanisms of cisplatin resistance
2011 Standout
Doxorubicin and C-13 Deoxydoxorubicin Effects on Ryanodine Receptor Gene Expression
2002
Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications
2003
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria
2007
Covalent and Noncovalent Interactions in Acute Lethal Cell Injury Caused by Chemicals
1990
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers
2008
Interactions of Adriamycin aglycones with mitochondria may mediate Adriamycin cardiotoxicity
1994
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
2010 Standout
Microfluidic organs-on-chips
2014 Standout
Dexrazoxane in the Prevention of Doxorubicin-Induced Cardiotoxicity
1994
Cardiotoxicity of Chemotherapeutic Agents
2000
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes
2005 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca2+ handling and contractile function in rat heart
2000
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Autophagy and Aging
2011 Standout
p53-dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury
2005
Canonical TRP channels and mechanotransduction: from physiology to disease states
2010
Molecular mechanisms of necroptosis: an ordered cellular explosion
2010 Standout
Self-eating and self-killing: crosstalk between autophagy and apoptosis
2007 Standout
Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria
2007
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
ROS Are Good
2016 Standout
Moderate and severe traumatic brain injury in adults
2008 Standout
Anthracycline drug targeting: cytoplasmic versus nuclear – a fork in the road
2001
AN ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR PROTECTS AGAINST DOXORUBICIN‐INDUCED IMPAIRMENT OF CALCIUM HANDLING IN NEONATAL RAT CARDIAC MYOCYTES
1997
The Hallmarks of Aging
2013 Standout
A TRPC6-Dependent Pathway for Myofibroblast Transdifferentiation and Wound Healing In Vivo
2012
Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies
2006
Structure and function of “metalloantibiotics”
2003
Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White Donors
2008
ROS and the DNA damage response in cancer
2018 Standout
Down syndrome
2020 Standout
CBR1andCBR3pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients
2008
ROS signalling in the biology of cancer
2017 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
2015
Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies
2010
Cross Talk of Nitric Oxide, Oxygen Radicals, and Superoxide Dismutase Regulates the Energy Metabolism and Cell Death and Determines the Fates of Aerobic Life
2003
Nox NADPH Oxidases and the Endoplasmic Reticulum
2014
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Engineering Adolescence
2014 Standout
In Vitro and In Vivo Characterizations of Pegylated Liposomal Doxorubicin
2011
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Biological functions of lymphatic vessels
2020 Science
Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
2003
Studies on free radicals, antioxidants, and co-factors.
2007
Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
2000
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels
2014
Doxorubicin directly binds to the cardiac-type ryanodine receptor
2002
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
2015 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
Role of Quinones in Toxicology
2000 Standout
Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats
2005
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Role of iron in anthracycline cardiotoxicity: new tunes for an old song?
1999
Heme-Containing Oxygenases
1996 Standout
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro.
1990
The Role of Mitochondria in Apoptosis
2009 Standout
Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum.
1990
Works of Baojun Chang being referenced
Edaravone Inhibits Acute Renal Injury and Cyst Formation in Cisplatin-Treated Rat Kidney
2004
Expression and Distribution of NADPH Oxidase Isoforms in Human Myometrium—Role in Angiotensin II-induced Hypertrophy1
2009
L‐carnitine inhibits hepatocarcinogenesis via protection of mitochondria
2004
Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice
2001
l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine
2002
Targeting Superoxide Dismutase to Renal Proximal Tubule Cells Inhibits Mitochondrial Injury and Renal Dysfunction Induced by Cisplatin
2001
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.
1988
TRPC channels are necessary mediators of pathologic cardiac hypertrophy
2010
Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function
2014